GSK5471713 for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Jan 2026: Trial registered, NCT07332455
  2. 10 Feb 2026: Trial started, NCT07332455

The trials

NCT07332455: First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

State
Under way
Phase
Phase 1 and Phase 2
People
54 planned
Started
10 Feb 2026
Primary completion
24 Mar 2028
Arms
Participants receiving GSK5471713
Results
None posted
  1. 12 Jan 2026: Trial registered
  2. 10 Feb 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.